Published in Am J Clin Pathol on March 01, 1987
Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. Gut (1991) 2.29
Observer variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut (2002) 2.16
Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut (1992) 1.96
Adenocarcinoma in Barrett's oesophagus: an overrated risk. Gut (1989) 1.88
Short segment Barrett's oesophagus: prevalence, diagnosis and associations. Gut (1997) 1.75
Cost effectiveness of detecting Barrett's cancer. Gut (1996) 1.63
Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction. Proc Natl Acad Sci U S A (1991) 1.62
Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology. Gut (2001) 1.62
Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg (1996) 1.61
Esophageal Adenocarcinoma and Its Rare Association with Barrett's Esophagus in Henan, China. PLoS One (2014) 1.53
The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. Ann Surg (1996) 1.39
Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region. Am J Pathol (1998) 1.36
Trends in incidence and prevalence of specialized intestinal metaplasia, barrett's esophagus, and adenocarcinoma of the gastroesophageal junction. World J Surg (2003) 1.23
Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma. Cancer Res (2008) 1.15
Photodynamic therapy of the normal rat stomach: a comparative study between di-sulphonated aluminium phthalocyanine and 5-aminolaevulinic acid. Br J Cancer (1992) 1.14
Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease? Gut (1998) 1.14
Adenocarcinoma in Barrett's esophagus. A clinicopathologic study of 65 cases. Ann Surg (1991) 1.13
The role of smoking and alcohol in metaplasia and cancer risk in Barrett's columnar lined oesophagus. Gut (1993) 1.11
Barrett's esophagus: histopathologic definitions and diagnostic criteria. World J Surg (2004) 1.10
Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial. Gut (2000) 1.10
Report of an Amsterdam working group on Barrett esophagus. Virchows Arch (2003) 1.08
Biochemical basis of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation: a study in patients with (pre)malignant lesions of the oesophagus. Br J Cancer (1998) 1.03
Adenocarcinoma arising in Barrett's oesophagus: evidence for the participation of p53 dysfunction in the dysplasia/carcinoma sequence. Gut (1994) 0.99
Alcohol consumption is associated with an increased risk of erosive esophagitis and Barrett's epithelium in Japanese men. BMC Gastroenterol (2008) 0.98
Value of DNA image cytometry in the prediction of malignant change in Barrett's oesophagus. Gut (1989) 0.95
Visceral obesity and the risk of Barrett's esophagus in Japanese patients with non-alcoholic fatty liver disease. BMC Gastroenterol (2009) 0.94
High grade dysplasia: surveillance, mucosal ablation, or resection? World J Surg (2003) 0.91
Overexpression of p53 protein in Barrett's syndrome with malignant transformation. J Clin Pathol (1993) 0.91
Current status and future perspectives on the etiology of esophageal adenocarcinoma. Front Oncol (2012) 0.89
Risk factors for the progression of endoscopic Barrett's epithelium in Japan: a multivariate analysis based on the Prague C & M Criteria. Dig Dis Sci (2008) 0.89
Cytochromes P450 are expressed in proliferating cells in Barrett's metaplasia. Neoplasia (1999) 0.89
Shape of Barrett's epithelium is associated with prevalence of erosive esophagitis. World J Gastroenterol (2010) 0.88
Validation of the Prague C & M criteria for the endoscopic grading of Barrett's esophagus by gastroenterology trainees: a multicenter study. Gastrointest Endosc (2012) 0.88
MUC4 is increased in high grade intraepithelial neoplasia in Barrett's oesophagus and is associated with a proapoptotic Bax to Bcl-2 ratio. J Clin Pathol (2004) 0.87
Prague C&M and Japanese criteria: shades of Barrett's esophagus endoscopic diagnosis. J Gastroenterol (2010) 0.84
Epithelial cell proliferative activity of Barrett's esophagus: methodology and correlation with traditional cancer risk markers. Dig Dis Sci (1998) 0.83
Endoscopic Resection with Ligation Using a Multi-Band Mucosectomy System in Barrett's Esophagus with High-Grade Dysplasia and Intramucosal Carcinoma. Therap Adv Gastroenterol (2009) 0.82
Expression of CD44H and CD44v3 in normal oesophagus, Barrett mucosa and oesophageal carcinoma. J Clin Pathol (1996) 0.82
Prophylactic esophagectomy in Barrett esophagus with high-grade dysplasia. Langenbecks Arch Surg (2003) 0.82
Multi-colour FISH in oesophageal adenocarcinoma-predictors of prognosis independent of stage and grade. Br J Cancer (2014) 0.81
Claudin expression in Barrett's esophagus and adenocarcinoma. Virchows Arch (2005) 0.80
The value of traditional upper endoscopy as a diagnostic test for Barrett's esophagus. Gastrointest Endosc (2008) 0.79
Screening for gastrointestinal cancer: an epidemiological review. Gut (1991) 0.79
A 52-year-old man with heartburn: should he undergo screening for Barrett's esophagus? Clin Gastroenterol Hepatol (2009) 0.78
The phenotype of gastric mucosa coexisting with Barrett's oesophagus. J Clin Pathol (2001) 0.78
Magnifying endoscopy for the diagnosis of specialized intestinal metaplasia in short-segment Barrett's esophagus. World J Gastroenterol (2013) 0.76
Synthesis and characterization of anti-EGFR fluorescent nanoparticles for optical molecular imaging. Bioconjug Chem (2013) 0.76
Surveillance in Barrett's oesophagus: a personal view. Postgrad Med J (2002) 0.75
The definition and management of Barrett's oesophagus: a case report, review of the literature and a suggestion for the future. BMJ Case Rep (2009) 0.75
Goblet Cell Ratio in Combination with Differentiation and Stem Cell Markers in Barrett Esophagus Allow Distinction of Patients with and without Esophageal Adenocarcinoma. Cancer Prev Res (Phila) (2016) 0.75
Endoscopic diagnosis of Barrett's esophagus. World J Gastroenterol (2012) 0.75
Metallothionein in human oesophagus, Barrett's epithelium and adenocarcinoma. Br J Cancer (2002) 0.75
Barrett's esophagus: model of neoplastic progression. World J Surg (2003) 0.75
Genetic alterations during colorectal-tumor development. N Engl J Med (1988) 26.82
Clues to the pathogenesis of familial colorectal cancer. Science (1993) 14.52
Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science (1989) 11.53
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A (1998) 9.66
Gene expression profiles in normal and cancer cells. Science (1997) 9.65
APC mutations occur early during colorectal tumorigenesis. Nature (1992) 9.50
Prevalence of ras gene mutations in human colorectal cancers. Nature (1987) 9.23
Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet (1994) 8.34
Identification of a chromosome 18q gene that is altered in colorectal cancers. Science (1990) 8.32
Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol (1983) 8.24
Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci U S A (1987) 7.12
Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun (1985) 6.57
Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science (1991) 6.15
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med (1993) 6.13
Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res (1999) 6.10
Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 5.68
A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst (1997) 5.68
Allelotype of colorectal carcinomas. Science (1989) 5.54
Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med (2001) 5.22
Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med (1994) 5.12
Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med (1996) 4.87
Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet (1997) 4.86
The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med (1997) 4.66
Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med (1987) 4.55
KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet (1997) 4.46
Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol (1994) 4.43
Clonal analysis using recombinant DNA probes from the X-chromosome. Cancer Res (1987) 4.25
Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet (1996) 4.09
Molecular diagnosis of familial adenomatous polyposis. N Engl J Med (1993) 4.07
Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet (1995) 4.01
Clonal analysis of human colorectal tumors. Science (1987) 3.72
Hypomethylation of DNA from benign and malignant human colon neoplasms. Science (1985) 3.72
Identification of p53 gene mutations in bladder cancers and urine samples. Science (1991) 3.68
The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology (1992) 3.59
Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science (1992) 3.58
Mismatch repair deficiency in phenotypically normal human cells. Science (1995) 3.55
Top-down morphogenesis of colorectal tumors. Proc Natl Acad Sci U S A (2001) 3.51
The APC gene product in normal and tumor cells. Proc Natl Acad Sci U S A (1993) 3.25
Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res (1995) 3.13
Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res (1997) 3.09
Genetic instability occurs in the majority of young patients with colorectal cancer. Nat Med (1995) 3.07
Ischemic injury in the cat small intestine: role of superoxide radicals. Gastroenterology (1982) 2.95
Detecting colorectal cancer in stool with the use of multiple genetic targets. J Natl Cancer Inst (2001) 2.93
Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat Med (1998) 2.91
Histopathological identification of colon cancer with microsatellite instability. Am J Pathol (2001) 2.90
Inhibition of apoptosis during development of colorectal cancer. Cancer Res (1995) 2.77
An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol (1994) 2.67
Petrosal approach for petroclival meningiomas. Neurosurgery (1988) 2.66
Molecular determinants of dysplasia in colorectal lesions. Cancer Res (1994) 2.62
Necrosis of the gastrointestinal tract in uremic patients as a result of sodium polystyrene sulfonate (Kayexalate) in sorbitol: an underrecognized condition. Am J Surg Pathol (1997) 2.57
Mad-related genes in the human. Nat Genet (1996) 2.51
Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors. Science (1985) 2.49
hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res (1994) 2.39
Clinical and pathological associations with allelic loss in colorectal carcinoma [corrected]. JAMA (1989) 2.29
Prospective, randomized trial of autotransfusion after routine cardiac operations. Ann Thorac Surg (1993) 2.09
Desmoid tumours in familial adenomatous polyposis. Gut (1994) 2.08
Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease. Gastroenterology (1984) 2.08
Intestinal necrosis due to sodium polystyrene (Kayexalate) in sorbitol enemas: clinical and experimental support for the hypothesis. Surgery (1987) 2.07
High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc Natl Acad Sci U S A (1991) 2.07
Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol (1988) 2.03
Chronic colitis with thickening of the subepithelial collagen layer (collagenous colitis): histopathologic findings in 15 patients. Hum Pathol (1987) 1.97
Increased cytosine DNA-methyltransferase activity during colon cancer progression. J Natl Cancer Inst (1993) 1.94
Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol (1997) 1.93
Hepatoblastoma and APC gene mutation in familial adenomatous polyposis. Gut (1996) 1.89
CpG island methylation in colorectal adenomas. Am J Pathol (2001) 1.88
The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology (1995) 1.86
Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology (2000) 1.86
Variable phenotype of familial adenomatous polyposis in pedigrees with 3' mutation in the APC gene. Gut (1998) 1.85
Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut (1993) 1.85
The long-term side effects of radiation therapy for benign brain tumors in adults. J Neurosurg (1990) 1.83
Colorectal neoplasia in juvenile polyposis or juvenile polyps. Arch Dis Child (1991) 1.81
Prevalence and importance of pigmented ocular fundus lesions in Gardner's syndrome. N Engl J Med (1987) 1.76
Inactivation of both APC alleles in human and mouse tumors. Cancer Res (1994) 1.75
Surgical management of Crohn's disease. Influence of disease at margin of resection. Ann Surg (1980) 1.75
Visual loss as a complication of spine surgery. A review of 37 cases. Spine (Phila Pa 1976) (1997) 1.75
Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome. Cancer Res (1998) 1.73
Sources of nonlinearity in cDNA microarray expression measurements. Genome Biol (2001) 1.70
General practitioners as providers of minor surgery--a success story? Br J Gen Pract (1997) 1.66
Sulindac suppresses tumorigenesis in the Min mouse. Carcinogenesis (1996) 1.62
Chiari I malformation: association with hypophosphatemic rickets and MR imaging appearance. Radiology (1995) 1.61
Sporadic fundic gland polyps: common gastric polyps arising through activating mutations in the beta-catenin gene. Am J Pathol (2001) 1.61
Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg (1996) 1.61
Rectal epithelial apoptosis in familial adenomatous polyposis patients treated with sulindac. Gut (1999) 1.59
Gene amplification of c-myc and N-myc in small cell carcinoma of the lung. Science (1986) 1.56
Dietary protein-induced colitis in breast-fed infants. J Pediatr (1982) 1.56
Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences. Am J Pathol (1998) 1.55
Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux. Am J Surg (1985) 1.53
Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors. Cancer Res (2000) 1.53
Local (immunoglobulin A) immune response by the intestine to cholera toxin and its partial suppression with combined systemic and intra-intestinal immunization. Infect Immun (1978) 1.52
Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues. Cancer Res (1996) 1.49
Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation. Gastroenterology (1994) 1.48
Polymerase delta variants in RER colorectal tumours. Nat Genet (1995) 1.47
Early alteration of cell-cycle-regulated gene expression in colorectal neoplasia. Am J Pathol (1996) 1.47
Strokes in children due to vertebral artery trauma. Neurology (1993) 1.45
Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic adenomatous polyposis coli gene alterations. Am J Pathol (2000) 1.44
Fibroepithelioma of Pinkus. Eccrine duct spread of basal cell carcinoma. Am J Dermatopathol (1994) 1.43
Prognostic significance of DNA replication errors in young patients with colorectal cancer. Ann Surg (1998) 1.42
Type and distribution of pulmonary parenchymal and vascular amyloid. Correlation with cardiac amyloid. Am J Med (1979) 1.41
Ileal adenomas after colectomy in nine patients with adenomatous polyposis coli/Gardner's syndrome. Gastroenterology (1979) 1.41